Strategies to Connect Patients at Federally Qualified Health Clinics With Evidence Based Tobacco Cessation Treatment
Multi-Level Interventions for Increasing Tobacco Cessation at Federally Qualified Health Clinics (FQHCs)
3 other identifiers
interventional
12,009
1 country
1
Brief Summary
This trial aims to connect tobacco using patients of Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) with evidence-based treatment to help them quit. The trial will evaluate multiple strategies, that target both clinics and for patients, to increase the number of patients who enroll in Utah Tobacco Quit Line treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2019
CompletedFirst Posted
Study publicly available on registry
April 3, 2019
CompletedStudy Start
First participant enrolled
July 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedResults Posted
Study results publicly available
September 8, 2026
CompletedSeptember 8, 2026
July 1, 2026
1.5 years
March 11, 2019
March 20, 2026
July 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reach
Defined as the count of tobacco users who enter Quitline treatment. This outcome measure will report the number of participants in each group who enrolled in Quitline treatment.
Up to 12 months
Secondary Outcomes (3)
Impact
At 12 months
Abstinence From Tobacco
At 12 months
Health-related Quality of Life
At 12 months
Study Arms (5)
Ask-Advise-Connect (AAC)
EXPERIMENTALSubjects who enrolled in Quitline within 2 weeks of the AAC intervention were not randomized to other interventions.
AAC, Text Messaging (TM)
EXPERIMENTALSubjects who did not enroll in Quitline within 2 weeks of AAC were randomized to TM. Subjects who enrolled in Quitline within 6 months of TM were not randomized to other interventions. TM: weekly text message for one month, followed by a monthly text message over the next 5 months.
AAC, Clinic Only (CO)
EXPERIMENTALSubjects who did not enroll in Quitline within 2 weeks of the AAC intervention were randomized to CO. Patients receive continued clinic-level EHR intervention only.
AAC, TM, Motivation And Problem-Solving (TM+MAPS)
EXPERIMENTALSubjects who did not enroll in Quitline w/in 2 weeks of AAC were randomized to TM. Subjects who did not enroll in Quitline w/in 6 months of TM were randomized to MAPS. TM: weekly text message for one month, then a monthly text message for 5 months MAPS: monthly text message plus up to 2 phone calls for 6-12 months after their clinic visit
AAC, TM, Text Messaging Continued (TM-Cont)
EXPERIMENTALSubjects who did not enroll in Quitline within 2 weeks of AAC were randomized to TM. Subjects who did not enroll in Quitline within 6 months of TM were randomized to TM-Cont. TM: weekly text message for one month, followed by a monthly text message over the next 5 months. TM-Cont: monthly text message for 6-12 months following each tobacco user's clinic visit
Interventions
AAC utilizes EHR capabilities to prompt clinic practice team members to assess patients' tobacco use status, advise them to quit, and directly and electronically connect interested patients w/ Quitline treatment. Patients were then called by the Quitline to enroll w/in 48 hours.
Patients received text messages that offer opportunities to enroll in the Quitline. Text messages were sent on behalf of each patient's CHC system included a brief motivational message, the Quit Line website/phone number, and response options to opt-out (stop receiving study interventions) or connect to Quitline.
Patients received MAPS calls from Community health workers (CHWs) trained in MAPS. MAPS is designed to help patients address the larger context in which tobacco use occurs, motivate patients towards a long-term goal of quitting tobacco, and identify and address barriers to quitting and engaging in treatment.
Quitlines provide free behavioral phone counseling, text messaging, online programs, and pharmacotherapy (e.g. Nicotine Replacement Therapy).
Eligibility Criteria
You may qualify if:
- Participants will be current tobacco users.
- Participants who speak English or Spanish.
- Participants will have a working cellphone that can accept texts and calls.
- Participants who present at participating community health center (CHC) clinics.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (1)
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, 84112, United States
Related Publications (1)
Fernandez ME, Schlechter CR, Del Fiol G, Gibson B, Kawamoto K, Siaperas T, Pruhs A, Greene T, Nahum-Shani I, Schulthies S, Nelson M, Bohner C, Kramer H, Borbolla D, Austin S, Weir C, Walker TW, Lam CY, Wetter DW. QuitSMART Utah: an implementation study protocol for a cluster-randomized, multi-level Sequential Multiple Assignment Randomized Trial to increase Reach and Impact of tobacco cessation treatment in Community Health Centers. Implement Sci. 2020 Jan 30;15(1):9. doi: 10.1186/s13012-020-0967-2.
PMID: 32000812DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- IIT Data Management Team
- Organization
- Research Compliance Office, Huntsman Cancer Institute
Study Officials
- PRINCIPAL INVESTIGATOR
David Wetter
Huntsman Cancer Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2019
First Posted
April 3, 2019
Study Start
July 20, 2021
Primary Completion
January 2, 2023
Study Completion
March 31, 2023
Last Updated
September 8, 2026
Results First Posted
September 8, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share